These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26400159)

  • 1. A novel high-throughput activity assay for the Trypanosoma brucei editosome enzyme REL1 and other RNA ligases.
    Zimmermann S; Hall L; Riley S; Sørensen J; Amaro RE; Schnaufer A
    Nucleic Acids Res; 2016 Feb; 44(3):e24. PubMed ID: 26400159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution crystal structure of a key editosome enzyme from Trypanosoma brucei: RNA editing ligase 1.
    Deng J; Schnaufer A; Salavati R; Stuart KD; Hol WG
    J Mol Biol; 2004 Oct; 343(3):601-13. PubMed ID: 15465048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional complementation of Trypanosoma brucei RNA in vitro editing with recombinant RNA ligase.
    Gao G; Simpson AM; Kang X; Rogers K; Nebohacova M; Li F; Simpson L
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4712-7. PubMed ID: 15781861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the Trypanosoma brucei REL1 RNA ligase specific for U-deletion RNA editing, and is the REL2 RNA ligase specific for U-insertion editing?
    Gao G; Simpson L
    J Biol Chem; 2003 Jul; 278(30):27570-4. PubMed ID: 12748175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescence-based reporter substrate for monitoring RNA editing in trypanosomatid pathogens.
    Moshiri H; Salavati R
    Nucleic Acids Res; 2010 Jul; 38(13):e138. PubMed ID: 20444864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
    Durrant JD; Hall L; Swift RV; Landon M; Schnaufer A; Amaro RE
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e803. PubMed ID: 20808768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei.
    Amaro RE; Schnaufer A; Interthal H; Hol W; Stuart KD; McCammon JA
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17278-83. PubMed ID: 18981420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uridine insertion/deletion RNA editing in trypanosomatid mitochondria: In search of the editosome.
    Osato D; Rogers K; Guo Q; Li F; Richmond G; Klug F; Simpson L
    RNA; 2009 Jul; 15(7):1338-44. PubMed ID: 19447916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors.
    Durrant JD; McCammon JA
    BMC Pharmacol; 2011 Aug; 11():9. PubMed ID: 21878090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthalene-based RNA editing inhibitor blocks RNA editing activities and editosome assembly in Trypanosoma brucei.
    Moshiri H; Acoca S; Kala S; Najafabadi HS; Hogues H; Purisima E; Salavati R
    J Biol Chem; 2011 Apr; 286(16):14178-89. PubMed ID: 21378165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing novel inhibitors of Trypanosoma brucei.
    Demir O; Amaro RE
    Methods Mol Biol; 2013; 993():231-43. PubMed ID: 23568474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of Trypanosoma brucei RNA editing ligase reveals regions critical for interaction with KREPA2.
    Mehta V; Sen R; Moshiri H; Salavati R
    PLoS One; 2015; 10(3):e0120844. PubMed ID: 25790471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
    Pedró-Rosa L; Buckner FS; Ranade RM; Eberhart C; Madoux F; Gillespie JR; Koh CY; Brown S; Lohse J; Verlinde CL; Fan E; Bannister T; Scampavia L; Hol WG; Spicer T; Hodder P
    J Biomol Screen; 2015 Jan; 20(1):122-30. PubMed ID: 25163684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot-scale compound screening against RNA editing identifies trypanocidal agents.
    Moshiri H; Mehta V; Yip CW; Salavati R
    J Biomol Screen; 2015 Jan; 20(1):92-100. PubMed ID: 25170016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening of compounds targeting RNA editing in Trypanosoma brucei: Novel molecular scaffolds with broad trypanocidal effects.
    Rostamighadi M; Kamelshahroudi A; Mehta V; Zeng FY; Pass I; Chung TDY; Salavati R
    Biochem Pharmacol; 2024 Jan; 219():115937. PubMed ID: 37995979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of the C-terminal domain of the largest editosome interaction protein and its role in promoting RNA binding by RNA-editing ligase L2.
    Park YJ; Budiarto T; Wu M; Pardon E; Steyaert J; Hol WG
    Nucleic Acids Res; 2012 Aug; 40(14):6966-77. PubMed ID: 22561373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
    Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
    Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
    Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
    J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
    Sykes ML; Baell JB; Kaiser M; Chatelain E; Moawad SR; Ganame D; Ioset JR; Avery VM
    PLoS Negl Trop Dis; 2012; 6(11):e1896. PubMed ID: 23209849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.